Why are some treatments made available to patients while others are not? On this course, you’ll explore how health technology assessment (HTA) informs whether we should have access to certain treatments on the NHS or other healthcare systems. You’ll learn how decisions are made about which treatments are made available and the considerations that made surrounding benefits and costs.
- How do we know if the treatment is of benefit?
- How can we make sense of all the evidence?
- How is evidence of the cost of drugs used in HTA?
- We’ll also explore how the final HTA report fits within the wider range of information used to make decisions about which treatments to fund.
This course is designed for anyone who works in a medical or pharmaceutical profession, or who studies a healthcare subject such as medicine, nursing, healthcare or health economics and wants to better understand HTA.
This course will also be helpful for a patient or interested member of the public who wants to understand the HTA story behind the headlines.
By the end of the course, you‘ll be able to…
- Explore the assessment process for a new health technology and how this applies to a potential decision outcome.
- Explain the process behind decisions about which healthcare treatments are funded to a patient or member of the public.
- Investigate a health technology assessment (HTA) and understand the evidence presented.
- Contribute to an informed discussion about whether or not a new health technology is adopted and funded by the NHS, or other national healthcare system.